Literature DB >> 10838414

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

.   

Abstract

The ability to identify active compounds (³hits²) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays. The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening. The criteria or parameters for evaluating the ³suitability² of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly. In this report, a screening window coefficient, called ³Z-factor,² is defined. This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment. The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay. The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.

Year:  1999        PMID: 10838414     DOI: 10.1177/108705719900400206

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  2000 in total

1.  A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease.

Authors:  Richard T Cummings; Scott P Salowe; Barry R Cunningham; Judyann Wiltsie; Young Whan Park; Lisa M Sonatore; Douglas Wisniewski; Cameron M Douglas; Jeffrey D Hermes; Edward M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

2.  Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate.

Authors:  Ashley A Reinke; Shih-Hon Li; Mark Warnock; Maxim E Shaydakov; Naga Sandhya Guntaka; Enming J Su; Jose A Diaz; Cory D Emal; Daniel A Lawrence
Journal:  J Biol Chem       Date:  2018-12-03       Impact factor: 5.157

3.  High-Content Assay Multiplexing for Vascular Toxicity Screening in Induced Pluripotent Stem Cell-Derived Endothelial Cells and Human Umbilical Vein Endothelial Cells.

Authors:  Yasuhiro Iwata; William D Klaren; Connie S Lebakken; Fabian A Grimm; Ivan Rusyn
Journal:  Assay Drug Dev Technol       Date:  2017-08-03       Impact factor: 1.738

4.  A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2.

Authors:  Alejandra M Petrilli; Marisa A Fuse; Mathew S Donnan; Marga Bott; Nicklaus A Sparrow; Daniel Tondera; Julia Huffziger; Corina Frenzel; C Siobhan Malany; Christophe J Echeverri; Layton Smith; Cristina Fernández-Valle
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

5.  Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds.

Authors:  Grace Qun Gong; Ke Wang; Xin-Chuan Dai; Yan Zhou; Rajesh Basnet; Yi Chen; De-Hua Yang; Woo-Jeong Lee; Christina Maree Buchanan; Jack Urquhart Flanagan; Peter Robin Shepherd; Ying Chen; Ming-Wei Wang
Journal:  Acta Pharmacol Sin       Date:  2018-07-23       Impact factor: 6.150

6.  Isolation of improved free fatty acid overproducing strains of Escherichia coli via Nile red based high-throughput screening.

Authors:  Spencer W Hoover; J Tyler Youngquist; Phil A Angart; Sydnor T Withers; Rebecca M Lennen; Brian F Pfleger
Journal:  Environ Prog Sustain Energy       Date:  2011-11-17       Impact factor: 2.431

7.  Investigation of connexin 43 uncoupling and prolongation of the cardiac QRS complex in preclinical and marketed drugs.

Authors:  M P Burnham; P M Sharpe; C Garner; R Hughes; C E Pollard; J Bowes
Journal:  Br J Pharmacol       Date:  2014-08-13       Impact factor: 8.739

8.  Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2.

Authors:  Simon M Vogel; Matthias R Bauer; Andreas C Joerger; Rainer Wilcken; Tobias Brandt; Dmitry B Veprintsev; Trevor J Rutherford; Alan R Fersht; Frank M Boeckler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

9.  Measurement of thyroid stimulating immunoglobulins using a novel thyroid stimulating hormone receptor-guanine nucleotide-binding protein, (GNAS) fusion bioassay.

Authors:  M Pierce; R Sandrock; G Gillespie; A W Meikle
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

10.  Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility.

Authors:  Li Ling Lee; HyungHo Ha; Young-Tae Chang; Matthew P DeLisa
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.